The regulatory landscape for actively personalized cancer immunotherapies

  • Cedrik M. Britten
  • , Harpreet Singh-Jasuja
  • , Bruno Flamion
  • , Axel Hoos
  • , Christoph Huber
  • , Karl Josef Kallen
  • , Samir N. Khleif
  • , Sebastian Kreiter
  • , Michaela Nielsen
  • , Hans Georg Rammensee
  • , Ugur Sahin
  • , Thomas Hinz
  • , Ulrich Kalinke

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)880-882
Number of pages3
JournalNature Biotechnology
Volume31
Issue number10
DOIs
StatePublished - Oct 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Bioengineering
  • Molecular Medicine
  • Biotechnology
  • Biomedical Engineering

Cite this